{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:49:44Z","timestamp":1789926584467,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Government of India","award":["BT\/PR4909\/MED\/30\/746\/2012"],"award-info":[{"award-number":["BT\/PR4909\/MED\/30\/746\/2012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neuroscience.2014.07.062","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T11:01:14Z","timestamp":1407409274000},"page":"818-830","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice"],"prefix":"10.1016","volume":"277","author":[{"given":"S.J.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Borkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.","family":"Nakhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Subhedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2014.07.062_b0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-2001-17205","article-title":"Cocaine\u2013amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice","volume":"33","author":"Asakawa","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0010","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.peptides.2006.07.020","article-title":"Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze","volume":"27","author":"Bacchi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1098\/rstb.2006.1855","article-title":"Neuropeptide Y in normal eating and in genetic and dietary-induced obesity","volume":"361","author":"Beck","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002097","article-title":"Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin","volume":"13","author":"Becker","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.neuroscience.2014.07.062_b0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0196-9781(81)90015-2","article-title":"Cholecystokinin in the central nervous system","volume":"2","author":"Beinfeld","year":"1981","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1176\/ajp.152.8.1180","article-title":"Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers","volume":"152","author":"Benkelfat","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.lfs.2009.10.007","article-title":"Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors","volume":"85","author":"Bhisikar","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2013.12.014","article-title":"Involvement of the central melanocortin system in the effects of caffeine on anxiety-like behavior in mice","volume":"95","author":"Bhorkar","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.peptides.2006.07.030","article-title":"Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis","volume":"28","author":"Bi","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0050","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/en.2004-0284","article-title":"Differential roles for cholecystokinin a receptors in energy balance in rats and mice","volume":"145","author":"Bi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0055","first-page":"178","article-title":"Neurobiological investigations into the role of cholecystokinin in panic disorder","volume":"18","author":"Bradwejn","year":"1993","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"234","author":"Bradwejn","year":"2001","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1994.03950060050005","article-title":"The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder","volume":"51","author":"Bradwejn","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nut.2008.06.007","article-title":"Y eat?","volume":"24","author":"Chee","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1460-9568.2006.05016.x","article-title":"Is the CCK2 receptor essential for normal regulation of body weight and adiposity?","volume":"24","author":"Chen","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2007.12.004","article-title":"Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration","volume":"152","author":"Chen","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0090","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0306-4522(85)90260-X","article-title":"The anatomy of neuropeptide-Y-containing neurons in mouse brain","volume":"15","author":"Chronwall","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0196-9781(94)90104-X","article-title":"Biological actions of cholecystokinin","volume":"15","author":"Crawley","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.npp.1301516","article-title":"Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal","volume":"33","author":"Dandekar","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroscience.2012.05.022","article-title":"Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice","volume":"218","author":"Del Boca","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2009.12.088","article-title":"Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences","volume":"1318","author":"Deo","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0091-3057(94)90467-7","article-title":"Heterogeneity of CCK-B receptors involved in animal models of anxiety","volume":"49","author":"Derrien","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01486-1","article-title":"Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety","volume":"713","author":"Duncan","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0143-4179(88)90045-5","article-title":"Characterization of [3H] CCK4 binding sites in mouse and rat brain","volume":"12","author":"Durieux","year":"1988","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"Review of 25 years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0135","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.17-05-01838.1997","article-title":"Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat","volume":"17","author":"Frankland","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0091-3057(97)00525-X","article-title":"Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression?","volume":"59","author":"Gonzalez","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pbb.2006.09.004","article-title":"Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt\u2019s test in rats","volume":"85","author":"Goyal","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0150","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/brain\/awf149","article-title":"The neuropathology of primary mood disorder","volume":"125","author":"Harrison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0155","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/j.1460-9568.2004.03704.x","article-title":"Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD-1 mice","volume":"20","author":"Hebb","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-2999(88)90182-3","article-title":"Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain","volume":"147","author":"Heilig","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(94)90115-5","article-title":"The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice","volume":"261","author":"Hernando","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jpsychires.2010.04.004","article-title":"CCK-4: psychophysiological conditioning elicits features of spontaneous panic attacks","volume":"44","author":"Hinkelmann","year":"2010","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0185","first-page":"250","article-title":"Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME","volume":"43","author":"Holy","year":"1998","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2009.03.038","article-title":"Behavioral effects and pattern of brain c-fos mRNA induced by 2,5-dihydro-2,4,5-trimethylthiazoline, a component of fox feces odor in GAD67-GFP knock-in C57BL\/6 mice","volume":"202","author":"Janitzky","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0195","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(96)00838-2","article-title":"Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam","volume":"317","author":"Kask","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0200","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1097\/00001756-199808240-00005","article-title":"NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test","volume":"9","author":"Kask","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(99)02383-5","article-title":"Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats","volume":"857","author":"Kask","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.mp.4000507","article-title":"Investigation of cholecystokinin system genes in panic disorder","volume":"4","author":"Kennedy","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0006-8993(03)03087-7","article-title":"Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress","volume":"983","author":"Kim","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2005.02.038","article-title":"Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats","volume":"1043","author":"Kokare","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vascn.2011.08.002","article-title":"A simple and inexpensive method to fabricate a cannula system for intracranial injections in rats and mice","volume":"64","author":"Kokare","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.peptides.2013.04.018","article-title":"Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats","volume":"47","author":"Kotagale","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10520290600763293","article-title":"The dynamic distribution of fluorogold and its interrelation with neural nitric oxide synthase following intracerebroventricular injection into rat brain","volume":"81","author":"Li","year":"2006","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0028-3908(97)00011-7","article-title":"The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat","volume":"36","author":"Matto","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0250","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0196-9781(97)00298-2","article-title":"Neuropeptide Y produces anxiety via Y2-type receptors","volume":"19","author":"Nakajima","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0260","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.tpj.6500234","article-title":"Comprehensive expression analysis of a rat depression model","volume":"4","author":"Nakatani","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2009.03.008","article-title":"Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats","volume":"609","author":"Nakhate","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.07.055","article-title":"Involvement of cocaine- and amphetamine-regulated transcript peptide in the hyperphagic and body weight promoting effects of allopregnanolone in rats","volume":"1532","author":"Nakhate","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(91)90037-Q","article-title":"Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260","volume":"193","author":"O\u2019Neill","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0280","series-title":"The mouse brain in stereotaxic co-ordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0285","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s000180300029","article-title":"Neuropeptide Y: the universal soldier","volume":"60","author":"Pedrazzini","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0290","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0295","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.npp.1300705","article-title":"Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors","volume":"30","author":"Primeaux","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0300","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90681-5","article-title":"Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety","volume":"172","author":"Rex","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0310","first-page":"171","article-title":"Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models","volume":"28","author":"Rotzinger","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0315","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-4328(01)00233-9","article-title":"Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze","volume":"126","author":"Silveira","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0330","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1073\/pnas.88.4.1130","article-title":"Evidence for an involvement of the brain cholecystokinin B receptor in anxiety","volume":"88","author":"Singh","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.npep.2009.05.003","article-title":"Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates","volume":"43","author":"Upadhya","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.lfs.2010.12.008","article-title":"Cocaine- and amphetamine-regulated transcript peptide increases spatial learning and memory in rats","volume":"88","author":"Upadhya","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0924-977X(96)00038-7","article-title":"Cholecystokinin in anxiety","volume":"6","author":"van Megen","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0350","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.17-23-09375.1997","article-title":"Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear","volume":"17","author":"Walker","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0355","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neubiorev.2005.05.008","article-title":"Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats","volume":"29","author":"Wang","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0360","first-page":"G628","article-title":"Cholecystokinin receptors","volume":"269","author":"Wank","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0365","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(90)90076-E","article-title":"Animal models of depression: an overview","volume":"45","author":"Willner","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0370","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02088832","article-title":"Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat","volume":"14","author":"Yee","year":"1994","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0375","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.1073\/pnas.0501988102","article-title":"Expression, physiological action, and coexpression patterns of neuropeptide Y in rat taste-bud cells","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.07.062_b0380","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00964510","article-title":"Transport and distribution of homocarnosine after intracerebroventricular and intravenous injection in the rat","volume":"9","author":"Ziesler","year":"1984","journal-title":"Neurochem Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214006356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214006356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:21:00Z","timestamp":1565702460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452214006356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":76,"alternative-id":["S0306452214006356"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2014.07.062","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}